ticagrelor
NDC 50228-521, ticagrelor, tablet, from ScieGen Pharmaceuticals INC.
- Product NDC
- 50228-521
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals INC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218962
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-521 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TICAGRELOR60 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P-Glycoprotein Inhibitors [MoA]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-521-10 | 50228052110 | 1000 TABLET in 1 BOTTLE (50228-521-10) |
| 50228-521-30 | 50228052130 | 30 TABLET in 1 BOTTLE (50228-521-30) |
| 50228-521-60 | 50228052160 | 60 TABLET in 1 BOTTLE (50228-521-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/40ac26dc-2570-de7e-e063-6294a90ade72NADAC price for package 50228052160
GET /v1/drugs/nadac/50228052160
Use it
Look up 50228-521 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-521 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-521. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.